Published

Evaluating psilocybin for the management of depression: a literature review

An abstract is available from the original source but is not redistributed by this tracker. Read the source record.

Open source BibTeX RIS

Bibliographic context

Journal: British Journal of Mental Health Nursing
Date: 2026-08-01
Source: Crossref
DOI: 10.12968/bjmh.2025.0020
PubMed: Unavailable

Authors

Sinclair Rachel

Watch author

Derived topics and classifications

psilocybin Depression Anxiety Aging Microdosing Wellbeing Review Article Safety Review Article

Citation graph

19 referenced DOIs found in stored source metadata. 1 indexed paper cite this DOI.

Open citation network

10.1016/j.neubiorev.2025.106132 10.1186/s12954-019-0308-4 10.7759/cureus.27336 10.1038/s41398-022-02039-0 10.1016/j.drudis.2016.01.016 10.1503/jpn.240037 10.1016/j.drugpo.2024.104691 10.7759/cureus.31796 10.1016/j.neuropharm.2023.109422 10.1177/2045125320950567 10.1007/7854_2017_478 10.1177/20503245211049313

Indexed papers citing this DOI

Evaluating psilocybin for the management of depression: a literature review2026-08-01

Related papers

Psychedelics and women's mental health: the effects of female sex hormones on psychedelics' efficacy and tolerability.Molecular Psychiatry · 2026-08-03 Psychedelic Therapies in the Management of Post-Traumatic Stress DisorderJournal of Education Health and Sport · 2026-07-15 Policy Considerations for Psychedelics in Research and Medicine - What’s Next on the Schedule?Journal of Science Policy & Governance · 2026-07-01 Study Protocol for "Exploring the safety and therapeutic potential of psilocybin in the treatment of anorexia nervosa in adolescents and young adults".PLoS ONE · 2026-06-29 Classical psychedelic microdosing, mood, and cognitive function: An umbrella review with narrative synthesis.Journal of Psychopharmacology · 2026-06-27 Beyond Psychedelic Microdosing: Therapeutic Potential, Neuropharmacology, and Safety Considerations in Low-Dose Psychoactive UseJournal of Advances in Developmental Research · 2026-06-17 Psilocybin-assisted therapy in treatment-resistant depression: rapid remission, uncertain durability, and the next phase of clinical evidenceAnnals of Medicine and Surgery · 2026-06-17 Psilocybin and Mental Health Outcomes: Scoping Review with ☸SAIMSARASAIMSARA Journal · 2026-06-14